"Benifuuki" green tea, containing O-methylated EGCG, reduces serum low-density lipoprotein cholesterol and lectin-like oxidized low-density lipoprotein receptor-1 ligands containing apolipoprotein B: A double-blind, placebo-controlled randomized trial

Journal of Functional Foods

Volumn 25, Issue , 2016, Pages 25-37

  Imbe, Hisashi ^a   Sano, Hiroyuki ^a   Miyawaki, Masahiro ^a   Fujisawa, Reiko ^a   Miyasato, Mai ^a,b   Nakatsuji, Fumihiko ^a   Haseda, Fumitaka ^a   Tanimoto, Keiji ^a   Terasaki, Jungo ^a   Maeda Yamamoto, Mari ^c   Tachibana, Hirofumi ^d   Hanafusa, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Benifuuki; Dyslipidaemia; Lectin like oxidized LDL receptor 1; LOX 1 ligand containing apolipoprotein B; O methylated catechin

Indexed keywords

EID: 84969793969     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.05.004     Document Type: Article

References (32)

1. Braitman L.E., Adlin E.V., Stanton J.L. Obesity and caloric intake: The national health and nutrition examination survey of 1971-1975 (HANES I). Journal of Chronic Diseases 1985, 38(9):727-732.
2. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: Findings from the third national health and nutrition examination survey. Journal of the American Medical Association 2002, 287(3):356-359.
3. Goto T., Saito Y., Morikawa K., Kanamaru Y., Nagaoka S. Epigallocatechin gallate changes mRNA expression level of genes involved in cholesterol metabolism in hepatocytes. The British Journal of Nutrition 2012, 107(6):769-773. 10.1017/S0007114511003758.
4. Hirano-Ohmori R., Takahashi R., Momiyama Y., Taniguchi H., Yonemura A., Tamai S., Umegaki K., Nakamura H., Kondo K., Ohsuzu F. Green tea consumption and serum malondialdehyde-modified LDL concentrations in healthy subjects. Journal of the American College of Nutrition 2005, 24(5):342-346.
5. Ikeda I., Imasato Y., Sasaki E., Nakayama M., Nagao H., Takeo T., Yayabe F., Sugano M. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochimica et Biophysica Acta 1992, 1127(2):141-146.
6. Ikeda I., Tsuda K., Suzuki Y., Kobayashi M., Unno T., Tomoyori H., Goto H., Kawata Y., Imaizumi K., Nozawa A., Kakuda T. Tea catechins with a galloyl moiety suppress postprandial hypertriacylglycerolemia by delaying lymphatic transport of dietary fat in rats. The Journal of Nutrition 2005, 135(2):155-159.
7. Inagaki H., Sugitani M., Setoguchi Y., Ito R., Oritani Y., Nishimura E., Sato S., Kato M., Sai M., Maeda-Yamamoto M., Kamei M. Effective suppression of adipose tissue weight gain in high-fat diet-fed mice by 'Benifuuki' green tea consumption. Nippon Shokuhin Kagaku Kogaku Kaishi 2009, 56(7):403-411. 10.3136/nskkk.56.403.
8. Inami S., Takano M., Yamamoto M., Murakami D., Tajika K., Yodogawa K., Yokoyama S., Ohno N., Ohba T., Sano J., Ibuki C., Seino Y., Mizuno K. Tea catechin consumption reduces circulating oxidized low-density lipoprotein. International Heart Journal 2007, 48(6):725-732.
9. Kakutani M., Ueda M., Naruko T., Masaki T., Sawamura T. Accumulation of LOX-1 ligand in plasma and atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits: Identification by a novel enzyme immunoassay. Biochemical and Biophysical Research Communications 2001, 282(1):180-185.
10. Kannel W.B., Dawber T.R., Kagan A., Revotskie N., Stokes J. Factors of risk in the development of coronary heart disease - six year follow-up experience. The Framingham Study. Annals of Internal Medicine 1961, 55:33-50.
11. Kim A., Chiu A., Barone M.K., Avino D., Wang F., Coleman C.I., Phung O.J. Green tea catechins decrease total and low-density lipoprotein cholesterol: A systematic review and meta-analysis. Journal of the American Dietetic Association 2011, 111(11):1720-1729. 10.1016/j.jada.2011.08.009.
12. Koo S.I., Noh S.K. Green tea as inhibitor of the intestinal absorption of lipids: Potential mechanism for its lipid-lowering effect. Journal of Nutritional Biochemistry 2007, 18(3):179-183. 10.1016/j.jnutbio.2006.12.005.
13. Kuriyama S., Shimazu T., Ohmori K., Kikuchi N., Nakaya N., Nishino Y., Tsubono Y., Tsuji I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki Study. Journal of the American Medical Association 2006, 296(10):1255-1265. 10.1001/jama.296.10.1255.
14. Leren P. The Oslo Diet-heart Study. Eleven-year report. Circulation 1970, 42(5):935-942.
15. Liu H.H., Li J.J. Aging and dyslipidemia: A review of potential mechanisms. Ageing Research Reviews 2015, 19:43-52. 10.1016/j.arr.2014.12.001.
16. Maeda-Yamamoto M., Ema K., Monobe M., Shibuichi I., Shinoda Y., Yamamoto T., Fujisawa T. The efficacy of early treatment of seasonal allergic rhinitis with Benifuuki green tea containing O-methylated catechin before pollen exposure: An open randomized study. Allergology International 2009, 58(3):437-444. 10.2332/allergolint.08-OA-0066.
17. Maeda-Yamamoto M., Ema K., Shibuichi I. In vitro and in vivo anti-allergic effects of 'Benifuuki' green tea containing O-methylated catechin and ginger extract enhancement. Cytotechnology 2007, 55(2-3):135-142. 10.1007/s10616-007-9112-1.
18. Masuda S., Maeda-Yamamoto M., Usui S., Fujisawa T. 'Benifuuki' green tea containing o-methylated catechin reduces symptoms of Japanese cedar pollinosis: A randomized, double-blind, placebo-controlled trial. Allergology International 2014, 63(2):211-217. 10.2332/allergolint.13-OA-0620.
19. Muramatsu K., Fukuyo M., Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. Journal of Nutritional Science and Vitaminology (Tokyo) 1986, 32(6):613-622.
20. Nagao T., Hase T., Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 2007, 15(6):1473-1483. 10.1038/oby.2007.176.
21. Nakagawa K., Miyazawa T. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. Journal of Nutritional Science and Vitaminology (Tokyo) 1997, 43(6):679-684.
22. Oka K., Yasuhara M., Suzumura K., Tanaka K., Sawamura T. Antioxidants suppress plasma levels of lectin like oxidized low-density lipoprotein receptor-ligands and reduce atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Journal of Cardiovascular Pharmacology 2006, 48(4):177-183. 10.1097/01.fjc.0000245989.89771.1b.
23. Okamura T., Sekikawa A., Sawamura T., Kadowaki T., Barinas-Mitchell E., Mackey R.H., Kadota A., Evans R.W., Edmundowicz D., Higashiyama A., Nakamura Y., Abbott R.D., Miura K., Fujiyoshi A., Fujita Y., Murakami Y., Miyamatsu N., Kakino A., Maegawa H., Murata K., Horie M., Mitsunami K., Kashiwagi A., Kuller L.H., Ueshima H. LOX-1 ligands containing apolipoprotein B and carotid intima-media thickness in middle-aged community-dwelling US Caucasian and Japanese men. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Atherosclerosis 2013, 229(1):240-245. ERA JUMP Study Group. 10.1016/j.atherosclerosis.2013.04.023.
24. Pedersen T.R., Kjekshus J., Berg K., Haghfelt T., Faergeman O., Faergeman G., Pyörälä K., Miettinen T., Wilhelmsen L., Olsson A.G., Wedel H. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Athersclerosis Supplements 1994, 5(3):81-87. Scandinavian Simvastatin Survival Study Group.
25. Robinson D., Hinohara S., Bevan E.A., Takahashi T. Seasonal variation in serum cholesterol levels in health screening populations from the U.K. and Japan. Journal of Medical Systems 1993, 17(3-4):207-211.
26. Sawamura T., Kume N., Aoyama T., Moriwaki H., Hoshikawa H., Aiba Y., Tanaka T., Miwa S., Katsura Y., Kita T., Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997, 386(6620):73-77.
27. Sawamura T., Wakabayashi I., Okamura T. LOX-1 in atherosclerotic disease. Clinica Chimica Acta 2015, 440:157-163. 10.1016/j.cca.2014.11.016.
28. Sone T., Kuriyama S., Nakaya N., Hozawa A., Shimazu T., Nomura K., Rikimaru S., Tsuji I. Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food and Nutrition Research 2011, 55. 10.3402/fnr.v55i0.8326.
29. Suzuki T., Kumazoe M., Kim Y., Yamashita S., Nakahara K., Tsukamoto S., Sasaki M., Hagihara T., Tsurudome Y., Huang Y., Maeda-Yamamoto M., Shinoda Y., Yamaguchi W., Yamada K., Tachibana H. Green tea extract containing a highly absorbent catechin prevents diet-induced lipid metabolism disorder. Scientific Reports 2013, 3:2749. 10.1038/srep02749.
30. Verschuren W.M., Jacobs D.R., Bloemberg B.P., Kromhout D., Menotti A., Aravanis C., Blackburn H., Buzina R., Dontas A.S., Fidanza F., Karvonen M.J., Nedeljkovic S., Nissinen A., Toshima H. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. Journal of the American Medical Association 1995, 274(2):131-136.
31. Wu A.H., Spicer D., Stanczyk F.Z., Tseng C.C., Yang C.S., Pike M.C. Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prevention Research (Phila) 2012, 5(3):393-402. 10.1158/1940-6207.CAPR-11-040.
32. Yoshimoto R., Fujita Y., Kakino A., Iwamoto S., Takaya T., Sawamura T. The discovery of LOX-1, its ligands and clinical significance. [Review]. Cardiovasc Drugs and Therapy 2011, 25(5):379-391. 10.1007/s10557-011-6324-6.